Metabolic-Fit / 100
NextMeds review
Compounded semaglutide at $79 a month and tirzepatide at $119, month to month, with no dose-based increase and — checked in its own checkout data rather than taken on trust — a renewal price identical to the joining price. That last part is rarer than it should be. Two things the homepage will not tell you. The $49 and $99 it advertises are the twelve-month totals divided by twelve, not a monthly rate you can start on, and the countdown beside them is not a real deadline: it read August 15th and then August 20th within the same hour. The larger caveat is corporate. NextMeds is operated by Trinity HealthCare Supply, LLC, which also runs Lean Meds, altRx and Trinity Meds, and that operator holds an open FDA warning letter.
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Every clinical figure in this piece is cited inline to its primary source — the trial or the FDA label — so you can open it and check us. This is background reading, not medical advice.
NextMeds at a glance
- Semaglutide
- $79/mo, same price at every dose
- Tirzepatide
- $119/mo, same price at every dose
- Coverage
- All 50 states
- Brand-name
- Compounded only
How we scored NextMeds
Every factor comes from NextMeds's own published pricing, disclosures and oversight, and the six combine into the 39/100 Metabolic-Fit Score by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
Cost is unpredictable or sits at the premium end.
Support is thin once the prescription ships.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we verified this review
- Last verified
- August 2026
- Confidence
- high
- Primary source
- nextmeds.com
$79 for semaglutide and $119 for tirzepatide, the same price at every dose, and every per-month figure reconciles exactly against its period total — more than most on this list manage. The 'Was $199' anchor beside them is a retired offer's renewal price, a rate this offer has never actually charged.
What to expect when you sign up
We walked NextMeds's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1The signup call to action stays on nextmeds.com (https://www.nextmeds.com/consultation?offer=offer_v9_tm)
What we noticed
- A monthly price is visible on the public homepage before any intake — you do not have to hand over information to see a number
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $79 | Injection, month to monthThe standing rate, and the renewal rate — declared as the same object as the joining price in the live offer's own checkout data. |
| Compounded semaglutide | $76 | Injection, 3-month plan$228 for the period. |
| Compounded semaglutide | $73 | Injection, 6-month plan$438 for the period. |
| Compounded semaglutide | $49 | Injection, 12-month plan$588 for the period. This is the figure the homepage advertises as its starting price. |
| Compounded tirzepatide | $119 | Injection, month to monthThe standing rate, and the renewal rate. |
| Compounded tirzepatide | $115 | Injection, 3-month plan$345 for the period. |
| Compounded tirzepatide | $110 | Injection, 6-month plan$660 for the period. |
| Compounded tirzepatide | $99 | Injection, 12-month plan$1,188 for the period. This is the second figure the homepage advertises. |
Swipe the table to see plan details →
Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what NextMeds's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.
What we like
- The renewal price is the same as the joining price on the live offer, confirmed in its own checkout data rather than from marketing copy
- Genuinely flat: the same rate at every dose on both molecules
- $79 month-to-month for semaglutide is among the lowest standing rates on this roster
- Every advertised per-month figure reconciles exactly against its period total ($228 over three months is $76, $588 over twelve is $49)
- Names two compounding pharmacies outright, with phone numbers — The Pharmacy Hub and Foothills Pharmacy
- Names its clinical group, OpenLoop Healthcare Partners, PC
- A full refund is available if a provider finds you medically ineligible
- Ships to all 50 states by its own FAQ
The caveats
- ⚠ Operated by Trinity HealthCare Supply, LLC, which also runs Lean Meds, altRx and Trinity Meds — four consumer brands from one company rather than four independent options
- ⚠ That operator carries an FDA warning letter: issued 8 June 2026 to Trinity HealthCare Supply, LLC dba altRx, MARCS-CMS 728236, for false and misleading claims and misbranding in telehealth, with no close-out recorded
- The advertised $49 and $99 are the twelve-month totals divided by twelve, printed under the words 'SAME PRICE EVERY MONTH'; the month-to-month rates are $79 and $119
- The 'Was $199' anchor beside them is the retired offer's renewal price, a rate this offer has never charged
- The countdown is not a deadline — it read 'ENDS AUGUST 15TH' and then 'AUGUST 20TH' within the same hour, and the offer's own stored end date is June 30th
- The 'Save $110' and 'Save $150' figures imply reference prices of $189 and $269, which do not match the $199 shown in the hero
- Your order becomes non-refundable as soon as you submit the intake, before a clinician has reviewed it
- Refund requests must be made in writing within 28 days of payment
- How many weeks of medication a charge buys is never stated — and its sibling brand Trinity Meds, on the same platform, defines its month as four weeks
- Nothing on the public site addresses pregnancy, breastfeeding, PCOS or menopause
- Compounded only, with no brand-name lane and no oral form
NextMeds for mothers: our verdict
Compounded semaglutide at $79 a month and tirzepatide at $119, month to month, with no dose-based increase and — checked in its own checkout data rather than taken on trust — a renewal price identical to the joining price. That last part is rarer than it should be. Two things the homepage will not tell you. The $49 and $99 it advertises are the twelve-month totals divided by twelve, not a monthly rate you can start on, and the countdown beside them is not a real deadline: it read August 15th and then August 20th within the same hour. The larger caveat is corporate. NextMeds is operated by Trinity HealthCare Supply, LLC, which also runs Lean Meds, altRx and Trinity Meds, and that operator holds an open FDA warning letter. It runs about $79/month, flat across every dose — toward the affordable end of what we track.
We weigh NextMeds the way mothers actually have to: not just the monthly cost, but postpartum and breastfeeding timing and PCOS and insulin resistance — the parts a general weight-loss roundup leaves out.
What NextMeds costs, in full
- Compounded semaglutide — Injection, month to month: $79/mo
- Compounded semaglutide — Injection, 3-month plan: $76/mo
- Compounded semaglutide — Injection, 6-month plan: $73/mo
- Compounded semaglutide — Injection, 12-month plan: $49/mo
- Compounded tirzepatide — Injection, month to month: $119/mo
- Compounded tirzepatide — Injection, 3-month plan: $115/mo
That sits below the roughly $179 median ongoing price across the providers we track for mothers — a real cost advantage.
NextMeds says the price covers the provider visit and the medication. That is the comparison that matters at this price: two providers a few dollars apart can differ by a hundred a month once the extras are counted, so line up what each one bundles before you decide.
The medications NextMeds prescribes
NextMeds prescribes semaglutide and tirzepatide — the two with the largest published weight-loss effects, and carrying both on one account matters when insulin resistance, common with PCOS and after gestational diabetes, makes tirzepatide the better-suited option. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
Where NextMeds fits — and where it doesn't — for mothers
A good fit if…
- the monthly cost is a real barrier and you want a low, predictable number.
- switching between semaglutide and tirzepatide may become necessary as your body and your hormones change.
- uninterrupted nationwide access matters — a move for family shouldn't interrupt care.
Look elsewhere if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- a clean regulatory record is a dealbreaker — note the FDA warning flagged in the cons above.
- you'd rather a prescriber talk through timing around postpartum and breastfeeding timing — that is the ground our #1 pick, CoreAge Rx, is built on.
Oversight, safety, and what we could verify
Everything NextMeds states publicly checked out at last review: pricing, pharmacies and clinical network were all verifiable. It carries an FDA warning letter, flagged in the cons — read it before starting. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
A standing caveat for mothers: GLP-1 medications aren't established as safe during pregnancy or breastfeeding, and every label advises against use. Nothing here changes that — plan the timing with your own clinician.
The bottom line
NextMeds is a provider we list only with full disclosure — weigh it on postpartum and breastfeeding timing and PCOS and insulin resistance against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: Someone who wants a genuinely flat month-to-month rate and will ignore both the countdown and the twelve-month headline — and who knows they are not choosing independently of Lean Meds or Trinity Meds.
Alternatives to NextMeds
Providers we have a referral relationship with, ordered by their Metabolic-Fit Score — highest first. This module leaves out the provider whose page you are reading, so on CoreAge Rx's own review our #1 pick is the one name you will not find here. These are not the whole roster: see the full ranking for every provider we cover, paid or not.
- Visit CoreAge Rx92
Metabolic-Fit / 100
CoreAge RxOur #1 pickOne flat price, both molecules on a single chart, and a prescriber who reads your history before writing — the most predictable place for a mother to start and, just as important, to pause.
- Visit Gala Health84
Metabolic-Fit / 100
A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included option if you can live with a yearly plan and a pharmacy it doesn't name.
- Visit Enhance MD81
Metabolic-Fit / 100
One of the more oversight-forward compounded programs here — lab work and a live provider visit bundled into every plan, with a gentle microdosing tier — the catch is that the low '$212' headline you'll see quoted is the 12-month prepay rate, not the $249 you'd pay month to month.
Keep comparing NextMeds
Head-to-head & alternatives
NextMeds, answered
- How much does NextMeds cost?
- At last review, NextMeds's lowest ongoing compounded rate was about $79 a month — $79/mo, same price at every dose for semaglutide, $119/mo, same price at every dose for tirzepatide. This market re-prices often, so check the current all-in figure at the source before committing.
- Is NextMeds safe to use while breastfeeding?
- Nothing in this class — compounded or brand — has been established as safe in pregnancy or lactation, and every label advises against use. NextMeds is not an exception to that. Plan a GLP-1 for after weaning and settle the timing with your own clinician.
- Does NextMeds offer both semaglutide and tirzepatide?
- Yes — NextMeds offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
- Where does NextMeds rank for mothers?
- NextMeds scores 39/100 on our Metabolic-Fit Score and sits at #206. That score is a weighted read of six things mothers actually have to care about. CoreAge Rx currently leads it — see how they compare.
Pricing, states and verification reflect NextMeds's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.